Neuren Pharmaceuticals | NEU - Assets

Stock Price
13.44
Daily Change
0.73 5.74%
Monthly
-22.89%
Yearly
-5.35%
Q1 Forecast
12.80

Neuren Pharmaceuticals reported AUD331.25M in Assets for its fiscal semester ending in June of 2025.





Assets Change Date
Akebia Therapeutics USD 376.56M 12.41M Dec/2025
Alaunos Therapeutics USD 3.72M 1.01M Sep/2025
Avita Medical AUD 58.13M 21.58M Jun/2025
Clinuvel Pharmaceuticals AUD 231.12M 19.44M Jun/2024
Dianthus Therapeutics USD 577.44M 251.37M Sep/2025
Genetic Signatures AUD 54.63M 4.38M Jun/2025
Ionis Pharmaceuticals USD 3.52B 490.91M Dec/2025
Medical Developments International AUD 66.4M 1.06M Jun/2025
Neuren Pharmaceuticals AUD 331.25M 78.46M Jun/2025
Organon & Co USD 13.55B 52M Sep/2025
Paradigm Biopharmaceuticals AUD 24.57M 10.79M Jun/2025
PYC Therapeutics AUD 183.28M 115.05M Jun/2025
Starpharma Holdings AUD 25.42M 4.19M Jun/2025
Tectonic Therapeutic USD 277M 18.31M Sep/2025
Telix Pharmaceuticals AUD 1.16B 25.97M Dec/2025
Viatris USD 37.92B 491.1M Sep/2025
Xeris Pharmaceuticals USD 370.19M 35.5M Sep/2025